Six Pharma CEOs To Testify In House as Democrats, Trump Compete For Attention On Drug Pricing
Executive Summary
While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.